MarketPeel
Insider Trading Intelligence
JP

Jeegar Pravinkumar Patel

EVMN
CHIEF SCIENTIFIC OFFICER · EVOMMUNE, INC. · CIK 0002092017
FILING MIX · LIFETIME45%/55%
BUYS
5
SELLS
6
TOTAL VALUE
$604.6K
COMPANIES
1
ACTIVE SINCE
Nov 2025
HOLDINGS NOW
46,403
AVG SELL PX
$21.29
TRADE KIND
SHOWING 11 / 11
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Jeegar Pravinkumar Patel. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
EVMN · 46,403 shares · as of Jun 22, 2026
044,90589,810134,714179,6192026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2026
2026
FLOW · 5 buys / 6 sellsCOVERAGE · 3 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
EVMN
EVOMMUNE, INC.
SALE10b5-1
10b5-1 plan
1,488$22.50$33.5K46,403Jun 22, 2026Jun 24, 2026View →
EVMN
EVOMMUNE, INC.
PURCHASE
Chief Scientific Officer
1,488$3.84$5.7K47,891Jun 22, 2026Jun 24, 2026View →
EVMN
EVOMMUNE, INC.
SALE
Chief Scientific Officer
1,48827,842Jun 22, 2026Jun 24, 2026View →
EVMN
EVOMMUNE, INC.
SALE10b5-1
10b5-1 plan
16,687$22.74$379.5K46,403Jun 1, 2026Jun 3, 2026View →
EVMN
EVOMMUNE, INC.
SALE
Chief Scientific Officer
13,51229,330Jun 1, 2026Jun 3, 2026View →
EVMN
EVOMMUNE, INC.
PURCHASE
Chief Scientific Officer
13,512$3.84$51.9K63,090Jun 1, 2026Jun 3, 2026View →
EVMN
EVOMMUNE, INC.
PURCHASEGRANT
Stock grant
69,31569,315Apr 16, 2026Apr 17, 2026View →
EVMN
EVOMMUNE, INC.
SALE
Chief Scientific Officer
7,513$17.84$134.0K49,578Dec 9, 2025Dec 11, 2025View →
EVMN
EVOMMUNE, INC.
SALE
Chief Scientific Officer
25,0000Nov 7, 2025Nov 12, 2025View →
EVMN
EVOMMUNE, INC.
PURCHASE
Chief Scientific Officer
3,17557,091Nov 7, 2025Nov 12, 2025View →
EVMN
EVOMMUNE, INC.
PURCHASEGRANT
Stock grant
179,619179,619Nov 5, 2025Nov 7, 2025View →
Other insiders · EVMN
Loading peer insiders…
About this filer
CIK 0002092017
ROLE
Chief Scientific Officer
PRIMARY
EVMN
COMPANIES
1
ACTIVE SINCE
Nov 2025
MARKETPEEL · /INSIDER/0002092017DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback